Johnson & Johnson announced Wednesday that Canada’s health agency has given full approval to its single-shot COVID-19 vaccine for people aged 18 years and above, making it the first to fully approve the vaccine globally.
Janssen Pharmaceuticals said in a statement on Wednesday that Health Canada has approved its vaccine, following a study that shows it to be 85 percent effective in preventing severe disease and protects against COVID-19 related hospitalization and death starting 28 days after the injection.
